Why the study?
Patients with ACS and aVR ST elevation are managed on the NSTE-ACS pathway rather than receiving primary PCI, despite worse outcomes and potential association with high-risk coronary artery stenosis.
Should patients with acute coronary syndrome and aVR ST segment elevation be treated on the primary percutaneous coronary intervention pathway?
Should patients with acute coronary syndrome and aVR ST segment elevation be treated on the primary percutaneous coronary intervention pathway?
aVR ST segment elevation in acute coronary syndrome is a high-risk finding associated with left main stem or multi-vessel disease, suggesting these patients should be triaged to the immediate primary PCI pathway.
No takes yet. Share an insight, caveat, or question.
aVR ST elevation may flag high-risk ACS anatomy; leaves open whether it warrants primary PCI pathway activation.
Sue Dean (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: